Table 1 Baseline characteristics of all adult patients
No mortality (n = 2773) | All mortality (n = 266) | p value | Early mortality (n = 134) | Late mortality (n = 132) | p value | |
|---|---|---|---|---|---|---|
Age (years) | 36.0 (29.0, 42.0) | 39.0 (32.0, 48.0) | < 0.01 | 39.0 (29.0, 42.0) | 39.0 (32.0, 47.8) | 0.78 |
Sex (female—n) | 1753 (63%) | 135 (51%) | < 0.01 | 69 (51%) | 66 (50%) | 0.81 |
BMI (kg/m2) | 24.6 ± 12.5 | 22.0 ± 5.4 | < 0.01 | 21.2 ± 4.7 | 23.4 ± 6.3 | 0.02 |
WHO stage (n) | Stage I: 1351 (51%) Stage II: 559 (21%) Stage III: 512 (19%) Stage IV: 241 (9%) | Stage I: 41 (17%) Stage II: 45 (18%) Stage III: 82 (33%) Stage IV: 79 (32%) | < 0.01 | Stage I: 19 (15%) Stage II: 20 (16%) Stage III: 43 (34%) Stage IV: 45 (35%) | Stage I: 21 (18%) Stage II: 26 (22%) Stage III: 38 (32%) Stage IV: 34 (28%) | 0.48 |
eGFR (mL/min/1.73 m2) | 130.5 ± 28.6 | 124.3 ± 29.0 | < 0.01 | 123.0 ± 32.2 | 125.7 ± 25.5 | 0.46 |
eGFR < 90 mL/min/1.73 m2 (n) | 187 (7%) | 35 (13%) | < 0.01 | 23 (17%) | 12 (9%) | 0.05 |
CD4 count (cells/µL) | 290.2 ± 222.5 | 165.1 ± 172.9 | < 0.01 | 141.9 ± 161.3 | 188.9 ± 181.5 | 0.03 |
CD4 count | 286 (10%) | 83 (31%) | < 0.01 | 52 (39%) | 31 (23%) | 0.01 |
Proteinuria (n) | 265 (9%) | 79 (30%) | < 0.01 | 44 (36%) | 35 (28%) | 0.20 |
Diabetes Mellitus (n) | 62 (2%) | 11 (4%) | 0.05 | 4 (3%) | 7 (5%) | 0.34 |
Hypertension (n) | 462 (17%) | 31 (12%) | 0.03 | 9 (7%) | 22 (17%) | 0.01 |